Skip to main content
. 2021 Jul 14;10(7):1784. doi: 10.3390/cells10071784

Table 3.

Pathway enrichment analysis (BioPlanet) of differentially regulated genes (DRGs) between pericytes cultured with and without endothelial cells (ECs).

Pathway Overlap Adj. p-Value
TGF-beta regulation of extracellular matrix 132/565 1.09 × 10−11
Epidermal growth factor receptor 1 (EGFR1) pathway 45/152 2.32 × 10−6
Brain-derived neurotrophic factor (BDNF) signaling pathway 63/261 8.33 × 10−6
T cell receptor regulation of apoptosis 118/603 8.33 × 10−6
Follicle-stimulating hormone (FSH) regulation of apoptosis 63/263 8.77 × 10−6
Messenger RNA processing 52/203 1.14 × 10−5
Interleukin-1 regulation of extracellular matrix 36/120 1.64 × 10−5
Interferon alpha/beta signaling 24/64 2.03 × 10−5
Smooth muscle contraction 13/22 2.41 × 10−5
Interferon signaling 44/168 3.61 × 10−5
Interleukin-2 signaling pathway 149/847 5.46 × 10−5
Ataxia telangiectasia mutated (ATM) pathway 19/48 1.05 × 10−4
Interleukin-4 regulation of apoptosis 58/267 3.54 × 10−4
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha) 31/112 4.19 × 10−4
Lipid and lipoprotein metabolism 92/489 4.28 × 10−4
Fatty acid, triacylglycerol, and ketone body metabolism 41/173 8.60 × 10−4
Activator protein 1 (AP-1) transcription factor network 22/70 9.30 × 10−4
Integrated breast cancer pathway 37/152 1.07 × 10−3
Retinoic acid receptor-mediated signaling 13/30 1.09 × 10−3
Gene expression 158/968 1.17 × 10−3
Angiogenesis 11/23 1.34 × 10−3
Senescence and autophagy 27/99 1.34 × 10−3
Uridine diphosphate (UDP)-N-acetyl-glucosamine biosynthesis 5/5 1.34 × 10−3
Capped intron-containing pre-mRNA processing 34/138 1.34 × 10−3
Type II interferon signaling (interferon-gamma) 17/50 1.91 × 10−3

Pathway enrichment analysis of differentially regulated genes (DRGs) between pericytes cultured with and without endothelial cells. Analysis was performed using NCATS BioPlanet on the Enrichr website by uploading DRGs as determined by the Transcriptome Analysis Console (TAC). Second column describes number of regulated genes compared to total number of genes in the pathway, and p-values adjusted for multiple testing are denoted in the last column. The 25 most significant pathways are listed.